Search OUR COMPANY HUMAN NUTRITION & HEALTH ANIMAL NUTRITION & HEALTH SPECIALTY PRODUCTS CONTACT US Home>Our Company>Investor Relations Investor Relations Investor Relations We welcome you to explore our Investor Relations portal, where you can get to know our goals and strategies to support your investment decision and increase long-term shareholder value. NASDAQ: — $– — Change — Volume — Today’s Open $– Previous Close $– Today’s High $– Today’s Low $– 52 Week High $– 52 Week Low $– Pricing delayed by 15 minutes. Last Updated… Current Financials 3rd Quarter 2021 Results Balchem reported third quarter 2021 net earnings of $25.0 million for 2021, compared to net earnings of $21.6 million for the third quarter 2020, record third quarter adjusted net earnings of $30.0 million, compared to $26.9 million in the prior year quarter, and record third quarter adjusted EBITDA of $48.3 million, compared to $44.4 million in the prior year quarter. View Report View Presentation Investor Relations Information Leadership & Governance Press Releases Events & Presentations Financial Reports Let Us Know How We Can Help You At Balchem, we have years of experience working with a vast network of customers spanning across various industries. We encourage you to reach out to our team of experts with any questions, comments, or concerns you may have about our business segments or products. Building a better tomorrow starts here. CONTACT US Newsletter Signup Sign up for our newsletter to receive the latest Balchem news. Facebook LinkedIn Our Company Investor Relations Press Releases Human Nutrition & Health Animal Nutrition & Health Specialty Products Careers Contact Us Privacy Policy | Terms & Conditions | California Transparency in Supply Chains Act of 2010 | Cookie Policy | Accessibility © 2021 Balchem Inc., All rights reserved. We use cookies to optimize our website and our service. Cookie Policy Accept